May 11, 2021
Business News

Sherlock Biosciences’ CRISPR SARS-CoV-2 Test Selected as Finalist in “On the Rise” and Honorable Mention in “Health and Pandemic Response” Categories of Fast Company’s 2021 World Changing Ideas Awards

CAMBRIDGE, Mass.–()–Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, has been named a finalist in the “On the Rise” and honorable mention in the “Health and Pandemic Response” categories for its Sherlock™ CRISPR SARS-CoV-2 kit as part of Fast Company’s 2021 World Changing Ideas Awards, announced today. These awards honor the businesses, policies, projects and concepts that are actively engaged and deeply committed to pursuing innovation when it comes to solving health and climate crises, social injustice or economic inequality.

Sherlock Biosciences’ SARS-CoV-2 test utilizes the SHERLOCK diagnostic platform, which can…

Click here to view the original article.

Related Posts

You might also like ...

Alida Named a Contender in Customer Feedback Management by Independent Research Firm
Healthgrades Announces the Recipients of the Healthgrades 2021 Patient Safety Excellence Awards and Healthgrades 2021 Outstanding Patient Experience Awards
T-Mobile US, Inc. to Present at the MoffettNathanson 2021 Media & Communications Virtual Summit